CHRISTOPHER SINCLAIR: Open Payments
NPI 1205987351 · PORT JEFFERSON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,812 in 24 payments from 9 companies in 2025. Trend: 2023 $644 · 2024 $164 · 2025 $8,812
Consulting: $6,613Travel & lodging: $1,133Food & beverage: $1,066
| Company | Payments | Amount |
|---|---|---|
| ARGENX US, INC. | 10 | $8,346 |
| Neurelis, Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $118 |
| Xeris Pharmaceuticals, Inc. | 4 | $75 |
| AtriCure, Inc. | 2 | $43 |
| UCB, Inc. | 1 | $35 |
| Biogen, Inc. | 1 | $28 |
| HOSPIRA, INC. | 1 | $25 |
| PFIZER INC. | 1 | $17 |
Products named: VYVGART HYTRULO, VALTOCO, HYQVIA, KEVEYIS, OCTAGAM IMMUNE GLOBULIN (HUMAN), Nayzilam, SYNERGY ABLATION SYSTEM, TYSABRI.
Industry payments across NY — which companies pay providers there.
